日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Efficacy of neoadjuvant FOLFIRINOX in resectable pancreatic cancer (NeoFOL-R): study protocol for an international, multicenter, prospective, randomized controlled trial

新辅助FOLFIRINOX方案治疗可切除胰腺癌的疗效(NeoFOL-R):一项国际多中心前瞻性随机对照试验的研究方案

Jung, Hye-Sol; Choi, Julian; Park, Se Jun; Han, Youngmin; Cho, Young Jae; Yoon, Jeesun; Oh, Do-Youn; Yoon, Yoo-Seok; Kim, Jin Won; Lim, Chang-Sup; Park, Jin Hyun; Choi, In Sil; Hong, Tae Ho; Kim, Hyung Sun; Jeung, Hei-Cheul; Ahn, Keun Soo; Kim, Jin Young; Yu, Young-Dong; Kim, Ju Won; Hwang, Ho Kyoung; Lee, Choong-Kun; Choi, Hye Jin; Jung, Yun Kyung; Park, Kwonoh; Yoon, Jai Hoon; Han, In Woong; Hong, Jung Yong; Seo, Hyung Il; Do Yang, Jae; Jeon, So-Yeon; Yang, Seok Jeong; Chon, Hong Jae; Kwon, Wooil; Park, Joon Seong; Shan, Yan-Shen; Lee, Myung Ah; Jang, Jin-Young

Systemic treatment strategies for combined hepatocellular-cholangiocarcinoma: current evidence and future direction

肝细胞癌-胆管癌合并症的系统性治疗策略:现有证据与未来方向

Yoon, Jeesun

Phase II study evaluating the safety and efficacy of neratinib and trastuzumab biosimilar in patients with HER2 mutated advanced solid tumors: KCSG AL20-17/KM23 trial

一项评估奈拉替尼和曲妥珠单抗生物类似药治疗HER2突变晚期实体瘤患者的安全性和有效性的II期研究:KCSG AL20-17/KM23试验

Lee, Kyoungmin; Lee, Kyung-Hun; Kim, Dong-Wan; Yoon, Jeesun; Choi, Yoon Ji; Lee, Soohyeon; Kim, Ju Won; Park, Kyong Hwa; Choi, Wonyoung; Lee, Youngjoo; Ryu, Hyewon; Koo, Dong-Hoe; Lee, YunGyoo; Jeung, Hei-Cheul; Lee, Min-Young; Lee, Namsu; Kang, Myoung Joo; Lee, Jieun; Hong, Sook Hee; Kang, Eun Joo; Park, In Hae

Fadraciclib, a CDK2/CDK9 inhibitor, shows efficacy in biliary tract cancer and synergistic potential with olaparib and JQ1 based on MCL1 expression

法德拉西利(Fadraciclib)是一种 CDK2/CDK9 抑制剂,在胆道癌中显示出疗效,并且基于 MCL1 表达,与奥拉帕尼(olaparib)和 JQ1 具有协同作用的潜力。

Kim, Jae-Min; Nam, Ah-Rong; Oh, Kyoung-Seok; Bang, Ju-Hee; Jeong, Yoojin; Choo, Sea Young; Kim, Hyo Jung; Lee, Su In; Yoon, Jeesun; Kim, Tae-Yong; Oh, Do-Youn

Therapeutic potential of BOLD-100, a GRP78 inhibitor, enhanced by ATR inhibition in pancreatic ductal adenocarcinoma.

BOLD-100(一种 GRP78 抑制剂)在胰腺导管腺癌中的治疗潜力可通过 ATR 抑制而增强

Lee Su In, Nam Ah-Rong, Oh Kyoung-Seok, Kim Jae-Min, Bang Ju-Hee, Jeong Yoojin, Choo Sea Young, Kim Hyo Jung, Yoon Jeesun, Kim Tae-Yong, Oh Do-Youn

Prognostic value of the TP53 mutation in patients with pancreatic ductal adenocarcinoma receiving FOLFIRINOX

TP53突变在接受FOLFIRINOX方案治疗的胰腺导管腺癌患者中的预后价值

Kim, Min Kyu; Cho, In Rae; Kim, Yooeun; Choi, Jin Ho; Jung, Kwangrok; Kim, Jaihwan; Kim, Sheehyun; Yun, Hongseok; Yoon, Jeesun; Oh, Do-Youn; Kim, Kwangsoo; Lee, Sang Hyub

Recent Progress in Immunotherapy for Gastric Cancer

胃癌免疫治疗的最新进展

Yoon, Jeesun; Kim, Tae-Yong; Oh, Do-Youn

Prospective evaluation of metabolic intratumoral heterogeneity in patients with advanced gastric cancer receiving palliative chemotherapy

对接受姑息化疗的晚期胃癌患者进行肿瘤内代谢异质性的前瞻性评估

Yoo, Shin Hye; Kang, Seo Young; Yoon, Jeesun; Kim, Tae-Yong; Cheon, Gi Jeong; Oh, Do-Youn

Targeting Hypoxia Using Evofosfamide and Companion Hypoxia Imaging of FMISO-PET in Advanced Biliary Tract Cancer

在晚期胆道癌中,使用依沃福酰胺靶向治疗乏氧并结合FMISO-PET乏氧成像

Yoon, Jeesun; Kang, Seo Young; Lee, Kyung-Hun; Cheon, Gi Jeong; Oh, Do-Youn